Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nordic Pharmacon AB
AB
Active
Org 5568503162
Kanholmsvägen 51, 132 54
Saltsjö-Boo
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2011 · 15 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Nordic Pharmacon AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
10M
7M
5M
2M
0M
2021: 7M
7M
2021
2022: 7M (0% vs 2021)
7M
0%
2022
2023: 8M (+14% vs 2022)
8M
+14%
2023
2024: 8M (0% vs 2023)
8M
0%
2024
2025: 7M (-12% vs 2024)
7M
-12%
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
6 884
7 687
7 577
6 884
7 305
Staff expenses
−1 029
−1 444
−1 432
−1 422
—
EBITDA
120
−22
131
−69
88
Depreciation & amort.
—
—
—
—
−0
EBIT
120
−22
131
−69
88
Net financials
2
6
4
−32
−26
Profit before tax
122
−16
136
−101
61
Tax
−32
−0
−8
—
−12
Net profit
90
−16
127
−101
49
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
2 061
2 427
2 240
2 161
2 129
Equity
1 066
976
992
865
966
Long-term debt
—
—
—
—
0
Short-term debt
995
1 451
1 248
1 296
1 163
Total debt
995
1 451
1 248
1 296
1 163
Financial ratios
5-year trend
EBITDA margin
1,7 %
This company
15,8 %
Market median
This company
Market median
89% below market
2021
2025
Equity ratio
51,7 %
This company
38,2 %
Market median
This company
Market median
35% above market
2021
2025
Return on equity
8,4 %
This company
18,4 %
Market median
This company
Market median
54% below market
2021
2025
Net profit margin
1,3 %
This company
8,1 %
Market median
This company
Market median
84% below market
2021
2025
Asset turnover
3,34×
This company
1,12×
Market median
This company
Market median
198% above market
2021
2025
Debt / equity
0,93×
This company
0,62×
Market median
This company
Market median
50% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nordic Pharmacon AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
